"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

On March 28, the Food and Drug Administration approved Pluvicto, a new radiation agent able to treat patients with prostate ...

Moderately hypofractionated and conventionally fractionated radiotherapy demonstrate similar efficacy, but one ...

affecting 1 in 8 men. Prostate cancer is treatable, in most cases, when the cancer remains localized to the prostate gland. But if the cancer advances to stage 4, cancer cells can break away from ...

Moores Cancer Center at the University of California San Diego has received a $1 million donation from pharmaceutical company ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

In early stages, colon cancer is highly treatable but may be harder to treat in later stages. Read on to learn more about stage 1 colon cancer symptoms, what to look out for, and when screening ...

1.4 million new cases worldwide in 2022 ... Approximately 10% of cases are diagnosed after the cancer has spread. This stage of prostate cancer has a five-year survival rate of 37%.

According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime.

Researchers are warning that men who regularly dodge prostate cancer screening appointments are 45% more likely to die from the disease. Prostate cancer is the most common cancer among men and the ...

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...